Cancer drug price spikes 1,400% with no generic option
1,319 views · Published 2 January 2018 · 6:09 · Indexed 20 September 2026
Channel: CBS News · 2018 · News & Politics
For cancer patients, the medications they take are crucial to survive. A Wall Street Journal report looks into price-gouging, specifically on the brain cancer drug lomustine. Reporter Peter Loftus joins CBSN to talk about his article and the issues this creates for patients.
More from this channel
-
3:48
First Look With Katie Couric: From D.C.
-
3:08
First Look With Katie Couric: Nuclear Claims
-
6:05
First Look With Katie Couric: Ahead Of The Curve
-
6:44
First Look With Katie Couric: Team Effort
-
3:10
First Look With Katie Couric: N. Korea & Hawaii
-
2:32
First Look With Katie Couric: Healthy Seafood
-
1:46
First Look With Katie Couric: Sports In America
-
4:00
First Look With Katie Couric: New Foley Claims